NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
At her blog, Sally Rockey dives into National Institutes of Health funding data.
This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.